Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
UMP Healthcare Holdings Limited ( (HK:0722) ) has shared an update.
UMP Healthcare Holdings Limited reported relatively stable interim results for the six months ended 31 December 2025, with revenue edging down 1.0% year-on-year to HK$367.5 million while maintaining profitability. Earnings per share rose to 2.36 Hong Kong cents from 2.25 cents, and the board declared an unchanged interim dividend of 1.40 Hong Kong cents per share, signalling confidence in the company’s cash generation and balance-sheet resilience.
Despite modest top-line pressure, the company improved profit before tax by 2.8% to HK$23.3 million and grew profit attributable to shareholders by 2.5% to HK$18.4 million, reflecting cost discipline across employee benefits and depreciation. The increase in profits alongside stable dividends suggests that UMP Healthcare is managing operating efficiency in a challenging environment, supporting steady returns for shareholders and maintaining its competitive position in the healthcare services sector.
The most recent analyst rating on (HK:0722) stock is a Buy with a HK$0.50 price target. To see the full list of analyst forecasts on UMP Healthcare Holdings Limited stock, see the HK:0722 Stock Forecast page.
More about UMP Healthcare Holdings Limited
UMP Healthcare Holdings Limited, listed on the Hong Kong Stock Exchange, operates in the healthcare services industry, providing medical and related professional services in Hong Kong and the region. The group generates revenue primarily from clinical, diagnostic, and healthcare management services delivered through its network of clinics and associated platforms.
Average Trading Volume: 101,562
Technical Sentiment Signal: Buy
Current Market Cap: HK$376.4M
See more data about 0722 stock on TipRanks’ Stock Analysis page.